A new study has found that vitamin D deficiency is associated with reduced overall survival for patients with multiple myeloma.
Multiple myeloma is a type of cancer that forms in a category of white blood cells known as plasma cells. An important component of the immune system, plasma cells help the body fight infections by making antibodies that recognize and attack germs. In multiple myeloma, cancer cells accumulate in the bone marrow, the blood cell producing tissue at the center of bones, where they crowd out healthy cells. Areas of the body such as the pelvis, ribs, skull, and spine are often affected by this form of cancer.
Studies carried out by scientists at the Dr. Rath Research Institute have shown that a specific combination of micronutrients including vitamin C, the amino acids lysine and proline, and the green tea extract epigallocatechin gallate (EGCG) are able to block all key mechanisms that make cancer a deadly disease. These mechanisms include blocking the growth of tumors, inhibiting the formation of new blood vessels in tumors (angiogenesis), inhibiting the spread of cancer (metastasis), and inducing the natural death of cancer cells (apoptosis). The micronutrient combination used by the Dr. Rath Research Institute has successfully been tested against more than 40 different types of cancer.
To learn more about the natural control of cancer, read the groundbreaking book authored by Dr. Rath and Dr. Aleksandra Niedzwiecki, ‘Victory Over Cancer’. Free copies of the chapters from this book can be downloaded from our website.